摘要
目的 :探讨联合应用奥扎格雷和钠低分子肝素钙治疗急性脑梗塞的疗效。方法 :对我院收治的80例急性脑梗塞患者的临床资料进行回顾性分析,将其分为对照组和实验组。为对照组患者使用奥扎格雷钠进行治疗,为实验组患者联合应用奥扎格雷和低分子肝素钙进行治疗,比较两组患者治疗效果。结果 :实验组患者治疗的有效率明显高于对照组患者,差异显著(P<0.05),有统计学意义。在实验组患者中,有3例患者出现不良反应,其不良反应的发生率为7.5%。在对照组患者中,有7例患者出现不良反应,其不良反应的发生率为17.5%。与对照组患者相比,实验组患者不良反应的发生率较低,差异显著(P<0.05),有统计学意义。结论 :为急性脑梗塞患者联合应用奥扎格雷钠和低分子肝素钙进行治疗的效果确切,可显著改善其临床症状,而且安全性较高,此法值得在临床上推广应用。
Objective:To investigate the effect of sodium ozagrel and low molecular heparin calcium clinical effect in patients with acute cerebral infarction.Methods:80 cases of patients admitted to our hospital data were analyzed according to the method of treatment, patients were divided into two groups. The control group was given Ozagrel, experimental group combined with low molecular weight heparin calcium treatment, the therapeutic effect was compared between the two groups. Results:The effect is ideal treatment of experimental group was 95%, higher than that of the control group (85%) (P<0.05);the experimental group incidence rate of adverse reaction was 7.5%, lower than that of the control group(17.5%)(P<0.05).Conclusion: Acute cerebral infarction disease incidence rate is high, the ideal therapeutic effect of sodium ozagrel and low molecular weight heparin calcium inclinical use, can effectively improve the symptoms of patients, is worthy to be popularized.
关键词
奥扎格雷钠
低分子肝素钙
急性脑梗塞
临床效果
Oza Grey Na
low molecular heparin
acute cerebral infarction
clinical effect
